A Study Comparing Insulin Peglispro With Insulin Glargine as Basal Insulin Treatment
NCT01894568
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
388
Enrollment
INDUSTRY
Sponsor class
Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG:
Insulin Peglispro
DRUG:
Insulin Glargine
DRUG:
Oral Antihyperglycemic Medications (OAMs)
Sponsor
Eli Lilly and Company